ARTICLE | Company News
CombinatoRx names Corrigan CEO
January 7, 2010 3:17 AM UTC
CombinatoRx Inc. (NASDAQ:CRXX) hired Mark Corrigan as president and CEO. Corrigan, a CombinatoRx director, was previously EVP of R&D at Sepracor Inc., which was acquired by Dainippon Sumitomo Pharma Co. Ltd. (Tokyo:4506; Osaka:4506) last year. Corrigan replaces Robert Forrester, who departed to pursue other opportunities. ...